Abiopharma

🔍 HARRIS JOHN D (Executive)

Company: Kyndryl Holdings, Inc. (KD)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 17,844 shares of Common Stock at $13.45 per share (Direct)
  Date: 2026-07-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 77,986.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).
• REMARKS: Exhibit List - Exhibit 24.1 - Power of Attorney